TP53 and lip and oral cavity carcinoma: Since down-regulation of casein kinase 2α (CK2α) was associated with activation of p53 transcriptional activities in apoptosis of γ-bisabolene-treated oral cancer cells [7], the CK2α and CK2β expression in γ-bisabolene-treated neuroblastom cells was further characterized (Figure 7A–C).